TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
53
|
63
|
55 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-4
|
1
|
-9 |
| EBITDA |
-4
|
1
|
-9 |
| Total assets |
29
|
30
|
29 |
| Current assets |
29
|
30
|
29 |
| Current liabilities |
10
|
8
|
9 |
| Equity capital |
19
|
22
|
20 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
65.5%
|
73.3%
|
69.0% |
| Turnover per employee |
53
|
63
|
55 |
| Profit as a percentage of turnover |
-7.5%
|
1.6%
|
-16.4% |
| Return on assets (ROA) |
-13.8%
|
3.3%
|
-31.0% |
| Current ratio |
290.0%
|
375.0%
|
322.2% |
| Return on equity (ROE) |
-21.1%
|
4.5%
|
-45.0% |
| Change turnover |
-12
|
6
|
-13 |
| Change turnover % |
-19%
|
10%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.